SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-22-013282
Filing Date
2022-05-23
Accepted
2022-05-23 16:29:49
Documents
11
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 6K form6k.htm 6-K 6637
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 378336
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 16495
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 712
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 113501
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 4610
7 GRAPHIC exhibit99-1x001.jpg GRAPHIC 6318
8 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 57544
9 GRAPHIC exhibit99-2x1x1.jpg GRAPHIC 6341
10 GRAPHIC exhibit99-3x001.jpg GRAPHIC 182004
11 GRAPHIC exhibit99-3x002.jpg GRAPHIC 283234
  Complete submission text file 0001062993-22-013282.txt   1259407
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 22952087
SIC: 2834 Pharmaceutical Preparations